Showing 76 to 90 of 384 results
Statement on physiotherapist renewals
Statement on physiotherapist renewals from Andrew Smith, Executive Director of Regulation
HCPC response to DHSC healthcare regulation consultation
As we move forward with the wider programme of regulatory reform, we welcome this consultation to consider how the powers to introduce and remove professions from regulation might be used in the future.
HCPC response to PSA Performance Review
HCPC welcomes recognition of progress on key areas of activity and sets out plan for further improvement
What you need to know about being an expert witness
Being an expert witness is an opportunity to demonstrate high levels of expertise and professionalism in your own area of practise
Reclassification of Gabapentin and Pregabalin
From midnight on 1st April 2019, gabapentin and pregabalin will be reclassified as Schedule 3 controlled drugs, under the Misuse of Drugs Regulations (2001), and Class C of the Misuse of Drugs Act (1971)